top of page

$21 Million Revenue Compounding Pharmacy and Lab based in New York

Listing Code:

NYRX1L

State:

New York

Category:

Pharmacy

Asking Price:

$9,000,000

Revenue:

$21,000,000

NYRX1L
Company Background

PRIME exits and American Health Capital are pleased to introduce a compounding pharmacy for sale based in the New York City area that specializes in fertility services as well as weight loss, dermatology, and more. The company serves the local community with customized care for all their trusted patients. They own a magnificent state-of-the-art lab that follows and exceeds all safety standards.

Financial Summary

In 2022, the company had a gross revenue of $16,458,392 with an adjusted EBITDA of $183,645. In 2023, the company grew to a gross revenue of $19,923,037 with an adjusted EBITDA of $800,867. Growth is expected to continue into 2024, and the projected revenue is $21 million with a projected EBITDA of $1.15 million.

Areas of Growth

The growth over the trailing 12 months was due to expanding partnerships and implementing customized medicine to treat patients (compounding). The staff, who are all expected to stay on under new ownership, have a collective experience of 100+ years in the industry.

The current owners do not have the bandwidth to dedicate the proper time that is needed for this business to reach its full potential. There are many low hanging opportunities of growth that an experienced operator could implement and execute quickly.

Asking Price

The asking price for this opportunity is $9 million.

Inquire About This Listing:

In order to learn more about our listing, you must:

1. Complete a Buyer Profile:

This profile will be used to pre-qualify buyers and determine whether we can share additional details about our listings. If you have already completed a Buyer Profile, disregard.

YOU ONLY NEED TO COMPLETE A BUYER PROFILE ONCE. 

2. Sign NDA with Listing Code:

To learn more about this listing, you must sign an NDA. When completing the NDA, you will need to copy the exact LISTING CODE and LISTING TITLE.

Listing Code:

NYRX1L

Listing Title:

$21 Million Revenue Compounding Pharmacy and Lab based in New York

Heading 4

Contact the Team

Jack Eskenazi American Healthcare Capital

Jack Eskenazi

President/Founder

American HealthCare Capital

Dr. Allen Nazeri DDS MBA.jpg

Dr. Allen Nazeri 

Managing Partner

PRIME exits

Join our mailing list to receive our latest news, and listings.

Thanks for submitting!

About us
 

PRIME exits is a registration pending trademark for Nazeri & Company LLCan independent affiliate of American Healthcare Capital. Nazeri & Company, Co. Ltd. is an international subsidiary of Nazeri & Company LLC. We are a merger and acquisition advisory firm focused on the healthcare industry with a network of 50+ M&A analysts and advisors. 

 

Locations

Los Angeles

Las Vegas

Bangkok

Vancouver, BC

Milan, Italy

Contact us

 

1-800- 424-3388 HEAD OFFICE

1-310-625-7889 Jack Eskenazi

1-702-506-3392 Dr. Allen Nazeri 

Valuation Team

Jack@ahcteam.com

Allen@ahcteam.com

Allen@pexits.com

Prime exits Bar code
Association Corporate Growth Logo
PRIME exits member masource-logo
CM&AP PRIME exits
bottom of page